Page 10 - Dabur India

Dabur India shares hit fresh record high on robust growth outlook

Dabur India's healthcare products are set to witness strong performance over the medium-term as customers focus on immunity booster and healthy lifestyle

Dabur to spend Rs 550 cr on new MP plant in largest location-wise exposure

The firm has secured 51 acres of land and begun construction work for the initial phase, which is to be completed within the current financial year

Investors shun top FMCG stocks amid market rally; Tata Consumer outlier

M-cap of top 10 firms has risen 12% in 1 year, against 42% rally in Nifty50

Dabur, ICICI Pru: Stocks that Osho Krishan of Anand Rathi is bullish on

The 14-period RSI has seen positive crossover affirming the bullish stance in the Dabur counter from a short to medium-term perspective

Dabur India's consolidated net profit rises 34.4% in Q4 on low base

The maker of honey, chyawanprash, oils and juices had reported a net profit of Rs 281.6 crore last year

Dabur India hits fresh record high; m-cap crosses Rs 1-trillion mark

In the past one month, the stock rallied 8 per cent, against 4 per cent decline in the S&P BSE Sensex

FMCG prices jump as companies fight to contain commodity inflation

Companies are also looking for change in product mix and cost saving measures

HUL, Colgate among Nomura's top picks in case of GST slab rejig

The rate rejig, analysts say, will alter the tax burden on companies, which they expect to get passed on to the consumers

Dabur India shares decline 2% after block deals

A media report said Dabur promoter would sell 0.5 per cent equity stake to raise Rs 460 crore at Rs 509.65-520.05 per share

Dabur India PAT up 24% to Rs 494 cr in Q3, operating revenue rises 16%

OTC drugs, health supplements and immunity boosting products grow in healthy double digits

FMCG major Dabur's third quarter profit up 24 pc at Rs 494 crore

The firm was helped by the expansion of the distribution network and consumer centric innovations

A year of living and working in the shadow of Covid-19 pandemic

For many businesses, the need to have people coming into office has shrunk. For many others, however, it remains integral to their operations

Burger King, Nestle, Dabur: Analysts bet on FMCG stocks as economy recovers

The success of Burger King at the bourses has off-late reinforced belief in the sector, especially quick service restaurants (QSRs), provided the stocks are attractively valued

Top headlines: India may get 1st vaccine by Feb, FMCGs expand rural reach

India is likely to issue an emergency use authorisation to at least one Covid vaccine by the end of January and health workers will be the first to be inoculated. More headlines in our evening roundup

Dabur India nears 52-week high on strong volume growth in September qtr

The stock has rallied 5% in two trading days, quoting close to its 52-week high level of Rs 535 touched on October 6, 2020

Dabur India Q2 net up 20% to Rs 483 cr despite sharp rise in tax outgo

Domestic sales drive the numbers as operating revenue grows 14%

Covid triggers wave of innovations as consumers turn finicky about hygiene

From personal to home hygiene, new items succh as UV disinfectants, sanitising boxes, free-finger touch devices, DIY grooming kits gain traction

Stock picks by Ajit Mishra of Religare Broking: Buy Britannia Ind, Dabur

After a sharp dip in March 2020, Britannia Industries has recovered almost vertically and made a new record high at Rs 4,010 in July 2020

Lessons from Covid-19: Happiness in simple things, says Dabur India chief

Things have now settled down to a routine

Dabur Q1 profit falls 6% to Rs 341 cr; revenue dips 12.9% to Rs 1,979.9 cr

Dabur said during the quarter the company introduced a record number of new products and variants anchored on the consumer need for health, immunity and hygiene